Nanalysis Scientific Corp.
NSCIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $45 | $28 | $25 | $16 |
| % Growth | 59.8% | 14.7% | 54.7% | – |
| Cost of Goods Sold | $33 | $24 | $14 | $6 |
| Gross Profit | $13 | $4 | $10 | $10 |
| % Margin | 28% | 13.9% | 42.2% | 63.8% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $10 | $11 | $12 | $6 |
| SG&A Expenses | $11 | $12 | $14 | $8 |
| Sales & Mktg Exp. | $2 | $1 | $2 | $2 |
| Other Operating Expenses | $4 | $4 | $5 | $3 |
| Operating Expenses | $16 | $16 | $20 | $11 |
| Operating Income | -$3 | -$12 | -$10 | -$1 |
| % Margin | -7.6% | -40.8% | -39.9% | -7.4% |
| Other Income/Exp. Net | -$10 | -$5 | -$0 | -$1 |
| Pre-Tax Income | -$14 | -$17 | -$10 | -$2 |
| Tax Expense | -$0 | -$0 | -$0 | $0 |
| Net Income | -$14 | -$17 | -$10 | -$2 |
| % Margin | -29.9% | -59% | -39.9% | -11% |
| EPS | -0.12 | -0.16 | -0.11 | -0.033 |
| % Growth | 25% | -45.5% | -229.3% | – |
| EPS Diluted | -0.12 | -0.16 | -0.11 | -0.033 |
| Weighted Avg Shares Out | 111 | 99 | 91 | 59 |
| Weighted Avg Shares Out Dil | 111 | 99 | 92 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $5 | $5 | $3 |
| EBITDA | -$8 | -$9 | -$5 | $1 |
| % Margin | -16.8% | -31.1% | -21.2% | 8.6% |